← Leaderboards
David J Kuter
Massachusetts General Hospital
$4,427,404
Attributed
$4,427,404
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $890.9K · FY2005–12$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$4,427,404 · 3
By mechanism
R01$2,844,266 · 2
U01$1,583,138 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Nadia Carlesso$10,223,723
- Farouc Amin Jaffer$9,945,391
Others in their field
Top investigators on “Hemorrhage”
- Chanza Baytop · Westat, Inc.$271,217,917
- Daniel F Hanley · Johns Hopkins University$53,423,550
- Paula Darby Lipman · Westat, Inc.$52,512,411
- Daniel Woo · University Of Cincinnati$50,047,308
- Kartik Chandran · Albert Einstein College Of Medicine$48,256,020
- Robert F Garry · Scripps Research Institute, The$45,179,770
Research focus
HemorrhageClinical ResearchThrombopoietic FactorClinical TrialsPlasmaBiliary Tract SurgeryBlood PlateletsPublic Health Medicine (Field)ChronicThrombosisResearch PersonnelBiomedical FacilityLiver DisorderBiopsyLiverPatient Oriented ResearchPostoperative ComplicationsChemopreventionBlood TransfusionCooperative StudyHemostasisGamma GlobulinAdolescence (12-20)Adult Human (21+)
Grant awards (13)
MGH Transfusion Medicine and Hemostasis Network Clinical Core Center$82,688
U01 · FY2012 · HL · contact PI
MGH Transfusion Medicine and Hemostasis Network Clinical Core Center$157,500
U01 · FY2009 · HL · contact PI
A Proteogenomic Analysis of Platelets in Patients with Essential Thrombocythemia$568,447
R01 · FY2008 · HL · contact PI
A Proteogenomic Analysis of Platelets in Patients with Essential Thrombocythemia$579,224
R01 · FY2007 · HL · contact PI
A Proteogenomic Analysis of Platelets in Patients with *$597,940
R01 · FY2006 · HL · contact PI
Studies of rHuTPO in ITP and of rVlla in Liver Disease$292,950
U01 · FY2006 · HL · contact PI
Proteogenomic Analysis of Platelets in Thrombocythemia$585,655
R01 · FY2005 · HL
Studies of rHuTPO in ITP and of rVlla in Liver Disease$150,000
U01 · FY2005 · HL
Studies of rHuTPO in ITP and of rVlla in Liver Disease$300,000
U01 · FY2004 · HL
Studies of rHuTPO in ITP and of rVlla in Liver Disease$300,000
U01 · FY2003 · HL
Studies of rHuTPO in ITP and of rVlla in Liver Disease$300,000
U01 · FY2002 · HL
MOLECULAR AND CELLULAR MECHANISMS OF PLATELET VIABILITY$256,500
R01 · FY2001 · HL
MOLECULAR AND CELLULAR MECHANISMS OF PLATELET VIABILITY$256,500
R01 · FY2000 · HL